Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques.

Johnston, Tom H

Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques. [electronic resource] - Movement disorders : official journal of the Movement Disorder Society 05 2019 - 708-716 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1531-8257

10.1002/mds.27565 doi


1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Animals
Antiparkinson Agents--adverse effects
Brain--diagnostic imaging
Dyskinesia, Drug-Induced--drug therapy
Levodopa--adverse effects
MPTP Poisoning--drug therapy
Macaca fascicularis
Movement--drug effects
Parkinsonian Disorders--chemically induced
Piperidines--pharmacology
Positron-Emission Tomography
Receptor, Muscarinic M2--metabolism
Receptor, Serotonin, 5-HT1A--metabolism
Receptor, Serotonin, 5-HT2A--metabolism
Receptors, Adrenergic, alpha-2--metabolism
Receptors, Dopamine D2--metabolism
Receptors, Dopamine D3--metabolism
Receptors, Histamine H3--metabolism
Receptors, sigma--metabolism
Sigma-1 Receptor